Report

reporttype1Version of Safety Report ID1receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10067752serious1Date Last Updated09/04/2014receiptdateformat102companynumbGB-RANBAXY-2014RR-79938occurcountryGBseriousnessother1duplicate1Date Received09/04/2014seriousnesshospitalization1transmissiondate12/12/2014primarysourcecountryGBseriousnessdisabling1

Primary Source

reportercountryGBqualification3

Patient

Onset Age35Unit of Onset AgeyearsWeight98SexMale

Contents

Reaction
- 1)
- 2)
- 3)
- 4)
- 5)
- 6)
- 7)
- 8)
- 9)
- 10)
- 11)
- 12)
Drug

Reaction

1)

reactionmeddraversionpt17.0ReactionDepressionOutcomeRecovered/resolved

2)

reactionmeddraversionpt17.0ReactionPanic attackOutcomeRecovered/resolved

3)

reactionmeddraversionpt17.0ReactionAnxietyOutcomeRecovered/resolved

4)

reactionmeddraversionpt17.0ReactionPalpitationsOutcomeRecovered/resolved

5)

reactionmeddraversionpt17.0ReactionExtrasystolesOutcomeRecovered/resolved

6)

reactionmeddraversionpt17.0ReactionHallucination, visualOutcomeRecovered/resolved

7)

reactionmeddraversionpt17.0ReactionDrug interactionOutcomeUnknown

8)

reactionmeddraversionpt17.0ReactionChronic fatigue syndromeOutcomeNot recovered/not resolved

9)

reactionmeddraversionpt17.0ReactionHyperhidrosisOutcomeRecovered/resolved

10)

reactionmeddraversionpt17.0ReactionHeadacheOutcomeRecovered/resolved

11)

reactionmeddraversionpt17.0ReactionFatigueOutcomeNot recovered/not resolved

12)

reactionmeddraversionpt17.0ReactionDepressed level of consciousnessOutcomeRecovered/resolved

Drug

1)

drugcharacterization1medicinalproductAMITRIPTYLINEdrugstructuredosagenumb50drugstructuredosageunit003drugdosagetext50 MG SELF TAPERING UP TO 70MGdrugadministrationroute048drugindicationNEURALGIAdrugstartdateformat102drugstartdate24/09/2013drugrecurreadministration3

2)

drugcharacterization1medicinalproductAMITRIPTYLINEdrugstructuredosagenumb70drugstructuredosageunit003drugdosagetext50MG SELF TAPERING UP TO 70MGdrugadministrationroute048drugindicationNEURALGIAdrugenddateformat102drugenddate14/02/2014actiondrug1drugrecurreadministration3

3)

drugcharacterization1medicinalproductSERTRALINEdrugauthorizationnumb077977drugstructuredosagenumb50drugstructuredosageunit003drugdosagetext50 MG INCREASED EVERY FEW WEEKS TO 150 MGdrugadministrationroute048drugindicationDEPRESSED MOODdrugstartdateformat102drugstartdate22/11/2013drugrecurreadministration3

openFDA Info on Medication

Application NumberANDA077670, ANDA077864, ANDA077397Brand NameSERTRALINEGeneric NameSERTRALINE, SERTRALINE HYDROCHLORIDEManufacturers Lupin Pharmaceuticals, Inc., Hikma Pharmaceuticals USA Inc., Exelan Pharmaceutic ... product_ndc 68180-351, 68180-352, 68180-353, 0143-9655, 0143-9656, 0143-9654, 76282-212, 762 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI312938, 312940, 312941spl_id 78d3579a-260f-4bb2-95f2-8ee8a60fae18, f35de481-61af-428e-abb4-a267238b3959, 5c8d ... spl_set_id 42120ff8-b353-4632-9ea9-54de9a698724, f9641190-9151-4f7e-89ff-1e7a818c30ee, 2dac ... Package NDC 68180-351-06, 68180-351-08, 68180-351-09, 68180-351-01, 68180-351-03, 68180-352- ... UNIIUTI8907Y6X

4)

drugcharacterization1medicinalproductSERTRALINEdrugauthorizationnumb077977drugstructuredosagenumb150drugstructuredosageunit003drugdosagetext50 MG INCREASED EVERY FEW WEEKS TO 150 MGdrugadministrationroute048drugindicationDEPRESSED MOODdrugenddateformat102drugenddate07/02/2014actiondrug1drugrecurreadministration3

openFDA Info on Medication

5)

drugcharacterization2medicinalproductDIAZEPAMdrugdosagetextUNKdrugadministrationroute065drugindicationPRODUCT USED FOR UNKNOWN INDICATIONdrugstartdateformat102drugstartdate29/01/2014drugenddateformat102drugenddate07/02/2014actiondrug5drugrecurreadministration3

openFDA Info on Medication

Application Number ANDA072079, ANDA071134, ANDA071135, ANDA071136, NDA020124, ANDA210363, NDA020648 ... Brand NameDIAZEPAM, DIASTAT, VALTOCO, VALIUMGeneric NameDIAZEPAMManufacturers Hospira, Inc., Mayne Pharma, Meridian Medical Technologies, Inc., Dash Pharmaceu ... product_ndc 0409-1273, 51862-062, 51862-063, 51862-064, 11704-600, 69339-136, 66490-650, 686 ... Product TypeHUMAN PRESCRIPTION DRUGRouteINTRAMUSCULAR, INTRAVENOUS, ORAL, RECTAL, NASALActive IngredientsDIAZEPAMspl_id 14233fc1-606a-4e78-8da4-df9eedb1c793, 49cd2631-74e5-4291-a491-b15b2fa31ee3, 26b3 ... spl_set_id 41044928-dd1f-40bf-1fa6-709dff559124, 7d81850c-ad3f-4e2e-ac41-ed9c567aea4b, fa35 ... Package NDC 0409-1273-03, 0409-1273-32, 51862-062-01, 51862-062-05, 51862-062-10, 51862-063- ... NUIN0000175694, M0002356Established Pharmacologic ClassBenzodiazepine [EPC]Chemical StructureBenzodiazepines [CS]UNIIQ3JTX2Q7TURXCUI197589, 197590, 197591, 2120550, 801957, 801961, 801966, 309843, 309844, 309845

Report Duplicate

duplicatesourceRANBAXYduplicatenumbGB-RANBAXY-2014RR-79938

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

5)

6)

7)

8)

9)

10)

11)

12)

Drug

1)

2)

3)

openFDA Info on Medication

4)

openFDA Info on Medication

5)

openFDA Info on Medication

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us